Temporal effects of the novel antitumour pyridyl cyanoguanidine (CHS 828) on human lymphoma cells

European Journal of Cancer

Volumn 37, Issue 2, 2001, Pages 260-267

  Martinsson, P ^a   Liminga, G ^a   Dhar, S ^a   De la Torre, M ^a   Lukinius, A ^a   Jonsson, E ^a   Bashir Hassan, S ^a   Binderup, L ^b   Kristensen, J ^a   Larsson, R ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LEO PHARMA A S   (Denmark)

Author keywords

Antineoplastic agent; Cell line; Cytotoxicity; Human lymphoma; Morphology

Indexed keywords

ANTINEOPLASTIC AGENT; GUANIDINE DERIVATIVE; N [6 (4 CHLOROPHENOXY)HEXYL] N' CYANO N'' (4 PYRIDYL)GUANIDINE; N [6 (4 CHLOROPHENOXY)HEXYL] N' CYANO N'' 4 PYRIDYLGUANIDINE; PYRIDYLCYANOGUANIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; CELL SURVIVAL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; HUMAN; HUMAN CELL; LYMPHOMA CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL SURVIVAL; CYANIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GUANIDINES; HUMANS; LYMPHOMA, LARGE-CELL; MICROSCOPY, ELECTRON; TUMOR CELLS, CULTURED;

EID: 0035134262     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00375-0     Document Type: Article

References (32)

1. Novel cyanoguanidines with potent oral antitumour activity
2. CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo
3. Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli
4. Induction of apoptosis in human leukemic U937 cells by tetrandine
5. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore
6. Apoptosis induction of human myeloid leukemic cells by ultrasound exposure
7. Apoptosis induction by the satratoxins and other trichothecene mycotoxins: Relationship to ERK, p38 MAPK, and SAPK/JNK activation
8. Induction of apoptosis in human hematopoietic U937 cells by granulocyte-macrophage colony-stimulating factor: Possible existence of caspase 3-like pathway
9. Anticancer drug-induced apoptosis in human monocytic leukemic cell line U937 requires activation of endonuclease(s)
10. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways
11. Establishment and characterization of a human histiocytic lymphoma cell line (U-937)
12. Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance
13. Apoptosis, necrosis, or oncosis: What is your diagnosis? A report from the Cell Death Nomenclature Committee of the Society of Toxicologic Pathologists
14. Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets
15. Automated monitoring of apoptosis in suspension cell cultures
16. Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis
17. Development of a high-volume in situ mRNA hybridization assay for the qualification of gene expression utilizing scintillating microplates
18. Noninvasive, real-time method for the examination of thymidine uptake events - Application of the method to V-79 cell synchrony studies
19. In vivo cultivation of tumor cells in hollow fibers
20. Early stimulation of acidification rate by novel cytotoxic pyridyl cyanoguanidines in human tumor cells: Comparison with m-iodobenzylguanidine
21. Calcein acetoxymethyl ester induces apoptosis in the human histiocytic lymphoma cell line U-937 GTB
22. Apoptosis induced by anticancer drugs
23. Cell death by apoptosis following anticancer drug treatment in vitro
24. Control of programmed cell death in normal and leukemic cells: New implications for therapy
25. Apoptosis and the dilemma of cancer chemotherapy
26. Apoptosis and chemotherapy resistance
27. Induction of apoptosis - New targets for cancer chemotherapy
28. Multiple pathways for apoptotic nuclear fragmentation
29. Neuronal cell death: A demise with different shapes
30. Do all programmed cell deaths occur via apoptosis?
31. Delayed internucleosomal DNA fragmentation in programmed cell death
32. Cell renewal and functional morphology of human lactating breast: Presentation of a new mode of cell death ('magentosis') characterized by nuclear periodic acid-Schiff reactivity